RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
PYC Therapeutics - Stock

PYC Therapeutics Dividend 2024

PYC Therapeutics Dividend

0 AUD

PYC Therapeutics Dividend yield

Ticker

PYC.AX

ISIN

AU000000PYC7

WKN

A0D8ZY

How much dividend does PYC Therapeutics 2024 pay?

According to the latest status from July 2024, PYC Therapeutics paid a total of 0 AUD per share in dividends within the last 12 months. With the current PYC Therapeutics price of 0.12 AUD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical PYC Therapeutics Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the PYC Therapeutics Dividend Safe?

PYC Therapeutics has been increasing the dividend for 0 years.

Over the past 10 years, PYC Therapeutics has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding PYC Therapeutics's Dividend Distributions

PYC Therapeutics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining PYC Therapeutics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

PYC Therapeutics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in PYC Therapeutics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

PYC Therapeutics Aktienanalyse

What does PYC Therapeutics do?

PYC Therapeutics Ltd is a biopharmaceutical company based in Sydney, Australia. The company was founded in 2017 by experienced pharmaceutical and biotech managers and currently employs over 40 employees. The history of PYC Therapeutics began with the development of a novel therapy platform called "PCytTM", which is based on the use of artificial proteins. These proteins can enhance the uptake of drugs into cells, thereby increasing the effectiveness of various medications. In 2018, PYC Therapeutics achieved a significant milestone by being included in the prestigious Accelerating Commercialisation program of the Australian government. PYC Therapeutics' business model focuses on the research and development of innovative cancer therapies and rare genetic diseases. The company strives to focus on diseases for which there is currently no effective treatment. This is intended to be achieved through partnerships, licensing, and potentially through the acquisition of companies and technologies. PYC Therapeutics shapes its processes through collaboration with experts in the fields of medicine, pharmacy, biotechnology, and chemistry. The divisions of PYC Therapeutics can be divided into the following areas of activity: drug development, platform technology, partnerships, and research and development. Under drug development, PYC Therapeutics understands the actual production of new cancer therapeutics and medications for the treatment of rare genetic diseases. The company relies on its internal research and also utilizes in-licensed technologies and acquisitions to develop novel drugs. Platform technology is a key success factor for PYC Therapeutics. The company has developed a highly effective method with PCytTM to optimize drug transport. This can significantly enhance the efficacy of medications. This technology has the potential to revolutionize the treatment of many diseases. Partnerships are an important part of PYC Therapeutics' business model. The company focuses on long-term collaborations with large pharmaceutical and biotech companies. This cooperation is intended to accelerate the development, approval, and commercialization of new medications. Research and development form the core of PYC Therapeutics' business model. The company invests significantly in the exploration of new therapeutics for cancer and rare genetic diseases. Since its inception, the company has continuously expanded its development platform and has become a key player in the industry. One of PYC Therapeutics' most important pipeline products is "PYC-06". PYC-06 is a medication developed for the treatment of acute myeloid leukemia (AML). The therapy aims to enhance the potential of chemotherapeutics by using PCytTM. The initial results of clinical studies show very promising results. Overall, PYC Therapeutics is an important player in the field of innovative cancer care and the treatment of rare genetic diseases. The company has a strong pipeline of novel therapeutics based on its PCytTM technology. PYC Therapeutics strives to improve the treatment of cancer and rare diseases and achieve a better quality of life for patients. The business model of PYC Therapeutics focuses on partnerships, innovative developments, and scientific research that contribute to advancing the industry. PYC Therapeutics is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about PYC Therapeutics Stock

How much dividend does PYC Therapeutics pay?

Over the past 12 months, PYC Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PYC Therapeutics is expected to pay a dividend of 0 AUD.

What is the dividend yield of PYC Therapeutics?

The current dividend yield of PYC Therapeutics is .

When does PYC Therapeutics pay dividends?

PYC Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PYC Therapeutics?

PYC Therapeutics paid dividends every year for the past 0 years.

What is the dividend of PYC Therapeutics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PYC Therapeutics located?

PYC Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von PYC Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PYC Therapeutics from 7/2/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.

When did PYC Therapeutics pay the last dividend?

The last dividend was paid out on 7/2/2024.

What was the dividend of PYC Therapeutics in the year 2023?

In the year 2023, PYC Therapeutics distributed 0 AUD as dividends.

In which currency does PYC Therapeutics pay out the dividend?

The dividends of PYC Therapeutics are distributed in AUD.

Andere Kennzahlen von PYC Therapeutics

Our stock analysis for PYC Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PYC Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.